These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 29164801)
1. Improving the biological function of decellularized heart valves through integration of protein tethering and three-dimensional cell seeding in a bioreactor. Namiri M; Kazemi Ashtiani M; Abbasalizadeh S; Mazidi Z; Mahmoudi E; Nikeghbalian S; Aghdami N; Baharvand H J Tissue Eng Regen Med; 2018 Apr; 12(4):e1865-e1879. PubMed ID: 29164801 [TBL] [Abstract][Full Text] [Related]
2. Modifying decellularized aortic valve scaffolds with stromal cell-derived factor-1α loaded proteolytically degradable hydrogel for recellularization and remodeling. Dai J; Qiao W; Shi J; Liu C; Hu X; Dong N Acta Biomater; 2019 Apr; 88():280-292. PubMed ID: 30721783 [TBL] [Abstract][Full Text] [Related]
3. Functional Oxidized Hyaluronic Acid Cross-Linked Decellularized Heart Valves for Improved Immunomodulation, Anti-Calcification, and Recellularization. Wu Y; Chen X; Song P; Li R; Zhou Y; Wang Q; Shi J; Qiao W; Dong N Adv Healthc Mater; 2024 Jun; 13(16):e2303737. PubMed ID: 38560921 [TBL] [Abstract][Full Text] [Related]
4. Engineering natural heart valves: possibilities and challenges. Namiri M; Ashtiani MK; Mashinchian O; Hasani-Sadrabadi MM; Mahmoudi M; Aghdami N; Baharvand H J Tissue Eng Regen Med; 2017 May; 11(5):1675-1683. PubMed ID: 26799729 [TBL] [Abstract][Full Text] [Related]
5. A riboflavin-ultraviolet light A-crosslinked decellularized heart valve for improved biomechanical properties, stability, and biocompatibility. Liu C; Qiao W; Cao H; Dai J; Li F; Shi J; Dong N Biomater Sci; 2020 May; 8(9):2549-2563. PubMed ID: 32226995 [TBL] [Abstract][Full Text] [Related]
6. In vitro generation of atrioventricular heart valve neoscaffolds. Weymann A; Radovits T; Schmack B; Li S; Korkmaz S; Soós P; Istók R; Veres G; Chaimow N; Karck M; Szabó G Artif Organs; 2014 Jul; 38(7):E118-28. PubMed ID: 24842040 [TBL] [Abstract][Full Text] [Related]
7. Non-physiologic Bioreactor Processing Conditions for Heart Valve Tissue Engineering. VeDepo MC; Buse EE; Paul A; Converse GL; Hopkins RA Cardiovasc Eng Technol; 2019 Dec; 10(4):628-637. PubMed ID: 31650518 [TBL] [Abstract][Full Text] [Related]
8. Decellularization and Recellularization of Rat Livers With Hepatocytes and Endothelial Progenitor Cells. Zhou P; Huang Y; Guo Y; Wang L; Ling C; Guo Q; Wang Y; Zhu S; Fan X; Zhu M; Huang H; Lu Y; Wang Z Artif Organs; 2016 Mar; 40(3):E25-38. PubMed ID: 26637111 [TBL] [Abstract][Full Text] [Related]
9. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells. Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187 [TBL] [Abstract][Full Text] [Related]
11. Chondroitin Sulfate Derivative Cross-Linking of Decellularized Heart Valve for the Improvement of Mechanical Properties, Hemocompatibility, and Endothelialization. Yan G; Fan M; Zhou Y; Xie M; Shi J; Dong N; Wang Q; Qiao W ACS Appl Mater Interfaces; 2024 Jul; 16(28):35936-35948. PubMed ID: 38958205 [TBL] [Abstract][Full Text] [Related]
12. Magnetically guided recellularization of decellularized stented porcine pericardium-derived aortic valve for TAVI. Ghodsizad A; Bordel V; Wiedensohler H; Elbanayosy A; Koerner MM; Gonzalez Berjon JM; Barrios R; Farag M; Zeriouh M; Loebe M; Noon GP; Koegler G; Karck M; Ruhparwar A ASAIO J; 2014; 60(5):582-6. PubMed ID: 25000385 [TBL] [Abstract][Full Text] [Related]
13. Complete dynamic repopulation of decellularized heart valves by application of defined physical signals-an in vitro study. Schenke-Layland K; Opitz F; Gross M; Döring C; Halbhuber KJ; Schirrmeister F; Wahlers T; Stock UA Cardiovasc Res; 2003 Dec; 60(3):497-509. PubMed ID: 14659795 [TBL] [Abstract][Full Text] [Related]
14. Promotion of adhesion and proliferation of endothelial progenitor cells on decellularized valves by covalent incorporation of RGD peptide and VEGF. Zhou J; Ding J; Nie B; Hu S; Zhu Z; Chen J; Xu J; Shi J; Dong N J Mater Sci Mater Med; 2016 Sep; 27(9):142. PubMed ID: 27541486 [TBL] [Abstract][Full Text] [Related]
15. The in vitro development of autologous fibrin-based tissue-engineered heart valves through optimised dynamic conditioning. Flanagan TC; Cornelissen C; Koch S; Tschoeke B; Sachweh JS; Schmitz-Rode T; Jockenhoevel S Biomaterials; 2007 Aug; 28(23):3388-97. PubMed ID: 17467792 [TBL] [Abstract][Full Text] [Related]